289 related articles for article (PubMed ID: 10160202)
1. Therapeutic aerosols and airway secretions.
Rubin BK
J Aerosol Med; 1996; 9(1):123-30. PubMed ID: 10160202
[TBL] [Abstract][Full Text] [Related]
2. An in vitro comparison of the mucoactive properties of guaifenesin, iodinated glycerol, surfactant, and albuterol.
Rubin BK
Chest; 1999 Jul; 116(1):195-200. PubMed ID: 10424525
[TBL] [Abstract][Full Text] [Related]
3. Improved clearability of cystic fibrosis sputum with dextran treatment in vitro.
Feng W; Garrett H; Speert DP; King M
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):710-4. PubMed ID: 9517580
[TBL] [Abstract][Full Text] [Related]
4. Mucus rheology and transport in neonatal respiratory distress syndrome and the effect of surfactant therapy.
Rubin BK; Ramirez O; King M
Chest; 1992 Apr; 101(4):1080-5. PubMed ID: 1555424
[TBL] [Abstract][Full Text] [Related]
5. Effects of dextran sulfate on tracheal mucociliary velocity in dogs.
Sudo E; Boyd WA; King M
J Aerosol Med; 2000; 13(2):87-96. PubMed ID: 11010598
[TBL] [Abstract][Full Text] [Related]
6. Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial.
Anzueto A; Jubran A; Ohar JA; Piquette CA; Rennard SI; Colice G; Pattishall EN; Barrett J; Engle M; Perret KA; Rubin BK
JAMA; 1997 Nov; 278(17):1426-31. PubMed ID: 9356001
[TBL] [Abstract][Full Text] [Related]
7. Effect of inhaled surfactant on pulmonary deposition and clearance of technetium-99m-DTPA radioaerosol.
Suga K; Mitra A; Domingues C; Alderson PO
J Nucl Med; 1998 Mar; 39(3):543-7. PubMed ID: 9529308
[TBL] [Abstract][Full Text] [Related]
8. The effect of synthetic surfactant Exosurf on gene transfer in mouse lung in vivo.
Raczka E; Kukowska-Latallo JF; Rymaszewski M; Chen C; Baker JR
Gene Ther; 1998 Oct; 5(10):1333-9. PubMed ID: 9930338
[TBL] [Abstract][Full Text] [Related]
9. Aerosol Medications for Treatment of Mucus Clearance Disorders.
Rubin BK
Respir Care; 2015 Jun; 60(6):825-9; discussion 830-32. PubMed ID: 26070577
[TBL] [Abstract][Full Text] [Related]
10. [Novel approach to respiratory pharmacology--pharmacological basis of cough, sputum and airway clearance].
Miyata T
Yakugaku Zasshi; 2003 Dec; 123(12):987-1006. PubMed ID: 14689863
[TBL] [Abstract][Full Text] [Related]
11. CPAP has no effect on clearance, sputum properties, or expectorated volume in cystic fibrosis.
Aquino ES; Shimura F; Santos AS; Goto DM; Coelho CC; de Fuccio MB; Saldiva PH; Lorenzi-Filho G; Rubin BK; Nakagawa NK
Respir Care; 2012 Nov; 57(11):1914-9. PubMed ID: 22417659
[TBL] [Abstract][Full Text] [Related]
12. Mucus structure and properties in cystic fibrosis.
Rubin BK
Paediatr Respir Rev; 2007 Mar; 8(1):4-7. PubMed ID: 17419972
[TBL] [Abstract][Full Text] [Related]
13. Effects of dextran on tracheal mucociliary velocity in dogs in vivo.
Feng W; Nakamura S; Sudo E; Lee MM; Shao A; King M
Pulm Pharmacol Ther; 1999; 12(1):35-41. PubMed ID: 10208834
[TBL] [Abstract][Full Text] [Related]
14. Physiology of airway mucus clearance.
Rubin BK
Respir Care; 2002 Jul; 47(7):761-8. PubMed ID: 12088546
[TBL] [Abstract][Full Text] [Related]
15. Exogenous surfactant therapy and mucus rheology in chronic obstructive airway diseases.
Banerjee R; Puniyani RR
J Biomater Appl; 2000 Jan; 14(3):243-72. PubMed ID: 10656543
[TBL] [Abstract][Full Text] [Related]
16. Physical and functional properties of airway secretions in cystic fibrosis--therapeutic approaches.
Puchelle E; de Bentzmann S; Zahm JM
Respiration; 1995; 62 Suppl 1():2-12. PubMed ID: 7792436
[TBL] [Abstract][Full Text] [Related]
17. Respiratory-related quality of life: relation to pulmonary function, functional exercise capacity, and sputum biophysical properties.
Piquette CA; Clarkson L; Okamoto K; Kim JS; Rubin BK
J Aerosol Med; 2000; 13(3):263-72. PubMed ID: 11066029
[TBL] [Abstract][Full Text] [Related]
18. Control of mucus secretion and ion transport in airways.
Nadel JA; Davis B; Phipps RJ
Annu Rev Physiol; 1979; 41():369-81. PubMed ID: 373597
[TBL] [Abstract][Full Text] [Related]
19. Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses.
Thomassen MJ; Antal JM; Connors MJ; Meeker DP; Wiedemann HP
Am J Respir Cell Mol Biol; 1994 Apr; 10(4):399-404. PubMed ID: 8136155
[TBL] [Abstract][Full Text] [Related]
20. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
Daviskas E; Anderson SD; Gomes K; Briffa P; Cochrane B; Chan HK; Young IH; Rubin BK
Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
